| Term 
 | Definition 
 
        | Trade name: dramamine   Mechanism of action: 1st generation H1 receptor antagonist   Clinical Use: Allergy, insomnia, itch, motion sickness   Side effects: Heavy sedation (***) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Trade name: Benadryl   Mechanism of action: 1st generation H1 receptor antagonist   Clinical Use: Allergy, insomnia, itch, motion sickness   Side effects: Heavy sedation (***) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Trade name: Atarax   Mechanism of action: 1st generation H1 receptor antagonist   Clinical Use: Allergy, insomnia, itch, motion sickness, vertigo, nausea, vomiting
   Side effects: Heavy sedation (***)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Trade name: poly-Histine-D   Mechanism of action: 1st generation H1 receptor antagonist   Clinical Use: Allergy, motion sickness, vertigo, nausea, vomiting   Side effects: Moderate sedation (**)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Trade name: Phenergan   Mechanism of action: 1st generation H1 receptor antagonist   Clinical Use: Insomnia, motion sickness, anti-emetic   Side effects: Heavy sedation (***) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Trade name: perlactin   Mechanism of action: 1st generation H1 receptor antagonist   Clinical Use: Allergy, migraine, Cushing's syndrome   Side effects: Moderate sedation (**)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Trade name: Dimetapp   Mechanism of action: 1st generation H1 receptor antagonist   Clinical Use: Allergy, common cold, rhinitis, potentiate analgesia   Side effects: LOW sedation (*)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Trade name: Allegra   Mechanism of action: 2nd generation H1 receptor antagonist   Clinical Use: Allergy, insomnia, itch, motion sickness, potentiate opioid analgesia   Side effects: NON-sedating   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Trade name: Allegra   Mechanism of action: 2nd generation H1 receptor antagonist   Clinical Use: Allergy, insomnia, itch, motion sickness, potentiate opioid analgesia   Side effects: NON-sedating     |  | 
        |  | 
        
        | Term 
 
        | Omeprazole (Prilosec®)  Lansoprazole (Prevacid®) Rabeprazole (AcipHex®) Pantoprazole (Protium®) Esomeprazole (Nexium®)     |  | Definition 
 
        | Class of drug:
 Proton pump inhibitors in parietal cell (irreversible) --> have to synthesize new pump 
 Mechanism of action: Taken as a prodrug --> acid resistant capsule (acid labile drugs) --> dissolve in intestinal lumen --> absorbed --> released where gastrin/somatostatin are released --> protonated in canaliculi --> bind channel and exert action   Clinical Use: heartburn, GERD, peptic ulcer from NSAID or H. pylor   Side effects: Vitamin B12 deficiency, Ca2+, Iron and zinc absorption issues. Take a supplement with them.       |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class of drug:
 Mucosal protective agent (use with PPI or H1 antagonist) 
 Mechanism of action: Reacts with HCl in stomach --> forms viscous paste & acid buffer --> complexes with albumin/fibrinogen creating protective barrier   Clinical Use: gastric/dudenal ulcers, stress related GI bleeding   Side effects: Constipation, flatulence     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class of drug:
 Mucosal protective agent (use with PPI or H1 antagonist)   Mechanism of action:  PGE1 analogue --> increases mucus/bicarbonate secretion, increase mucosal blood flow (activates PG-E3/E4 receptors on parietal cells --> Gi -->decrease cAMP --> counter histamine effects   Clinical Use: NSAID induced ulcers, gastric/dudenal ulcers using NSAIDs   Side effects: Diarrhea, abdominal pain         |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class of drug:
 Bismuth protective antacid   Mechanism of action: Unknown, but decreases inflammation and irritation of GI lining via protective coat action   Clinical Use:   H. pylori cocktail, dyspepsia, acute diarrhea       Side effects:   Black tongue/stools; Reyes Syndrome         |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class of drug:
   Pro-kinetic agent   
   Mechanism of action:   5-HT4 receptor antagonist --> ACh release in myenteric plexes --> stimulate gastric emtying.   It also inhibits D2 receptor (blocks ACh release)       Clinical Use:   GERD, IBS syndrome, gastritis, dyspepsia       Side effects:   Significant CNS effects (D2 is site for antisychotic drugs)         |  | 
        |  | 
        
        | Term 
 
        | Cimetidine (Tagament) Ranitidine (Zantac) Famotidine (Pepcid) Nizantidine (Axid) |  | Definition 
 
        | Class of drug:
   H2 receptor antagonists   
   Mechanism of action:   Blocks H2 receptor on the parietal cell --> no signal to increase HCl secretion       Clinical Use:   heartburn, GERD, peptic/gastric ulcers, stress related GI bleeding       Side effects:   Diarrhea, headache, fatigue, myalgias, constipation, gynecomastia at high concentrations --> increased estradiol effects   Potency:   famotidine > nizatidine =ranitidine > cimetidine       |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. Parietal cell --> secretes HCL in response to H2 binding (little also in response to ACh from vagus)   2. Enterochromaffin-like cell --> secretes Histamine onto parietal cell   3. G-cell --> in response to food in stomach secretes gastrin --> through antrum/fundis blood vessels --> gastrin binds receptor on ECC --> H2 release   4. D-cell --> releases somatostatin --> acts on G cell & stops gastrin release, aslo enters blood vessel and acts on ECC --> prevents H+ secretion   Acetylcholine can also activate --> ACh --> M3 on ECC (that releases histamine) and on parietal cell --> HCl release |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acute: 1. Beta2 agonists 2. Muscarinic antagonists 3. Theophylline   Chronic: 1. Long-acting Beta2 (improve response to steroids) 2. Corticosteroids 3. Inhibitors of mast cell mediator release 4. Anti-IgE antibodies   Prophylaxis: 1. Leukotriene antagonists |  | 
        |  |